Genomic Health
Illuminating Breast Cancer Recurrence Risk
 |   > Search     |  
Home Genomic Health Contact Us Register Online Portal


About Oncotype DX

What is Oncotype DX?
Who is Oncotype DX For?
How is Oncotype DX Performed?
How Can Oncotype DX Benefit Me?
Oncotype DX Results
How Do I Get a Test?

About Recurrence

Oncotype DX Development

Health Insurance Coverage

Frequently Asked Questions

Glossary

Helpful Links


Updated NCCN Guidelines

Register for Updates


How is Oncotype DX Performed?

Oncotype DX® is a non-invasive test that is performed on a small amount of the tissue removed during your original surgery (lumpectomy, mastectomy, or core biopsy). This means you do not have to undergo any additional invasive procedures for the test to be performed.

After your surgical procedure, the tissue sample is preserved and placed into a small container for further diagnostic testing. To perform Oncotype DX, the pathologist will send several thin sections of the preserved tumor tissue sample to Genomic Health®. The Oncotype DX test results are then integrated with other laboratory test results to help your doctor formulate a treatment plan based on the unique characteristics of your tumor.



Click here to view an animation of how Oncotype DX works.



Make a selection below to download the Oncotype DX process animation. For PC users, once the download is complete double-click on the file to uncompress it and double-click on oncotype_demo.exe to run the animation. For Mac users, once the download is complete simply click on the desktop icon.

PC Download
Mac Download

What's New?

November 11, 2008
Genomic Health to Present at Stephens Fall Investment Conference

November 10, 2008
Genomic Health Announces Publication of a Study Demonstrating the Oncotype DX(R) Breast Cancer Assay Influences Chemotherapy Treatment Recommendation in 44 Percent of Patients Evaluated


  © 2008 Genomic Health, Inc.  All rights reserved. | Home | Contact Us | Privacy | Terms and Conditions |